Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Safety Study in Patients With Chronic Lymphocytic Leukemia
This study has been completed.
Study NCT00283101 Information provided by Seattle Genetics, Inc.
First Received on January 25, 2006. Last Updated on June 6, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia, Lymphocytic, Chronic
Additional conditions recognized in this trial
Leukemia, Lymphocytic, Chronic, B-Cell
More general conditions related to this trial
Immune System Diseases
Neoplasms by Histologic Type
Interventions listed in this trial
SGN-40 (anti-huCD40 mAb)
Sponsors listed in this trial
Seattle Genetics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers